|

Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening

RECRUITINGSponsored by University of California, San Francisco
Actively Recruiting
SponsorUniversity of California, San Francisco
Started2015-01-08
Est. completion2026-01-31
Eligibility
Age25 Years – 49 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04927650

Summary

This study examines prevention and early detection of cervical cancer through self-administration screening of patients in Western Uganda. The cervix is the opening of the uterus or womb, which is the organ that supports babies before they are born. There are simple tests that let doctors know whether or not patients have cells that may become cancer. Some of the tests determine whether patients have an increased risk for cervical disease, but they do not actually confirm that they have it: these are called "screening" tests. This study may help researchers determine how to best deliver cervical cancer prevention services using the HPV test.

Eligibility

Age: 25 Years – 49 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Women in the three Ugandan districts (Kiboga, Kyankwanzi and Hoima) who access screening during the community health campaigns
* Age 25-49 years
* Resident in the study district
* Provision of informed consent

Exclusion Criteria:

* Clinical signs and symptoms of cancer of the cervix

Conditions3

CancerCervical CarcinomaHuman Papillomavirus-Related Carcinoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.